Cibc World Market Inc. Sells 3,322 Shares of Danaher Corporation $DHR

Cibc World Market Inc. cut its stake in shares of Danaher Corporation (NYSE:DHR) by 3.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 89,999 shares of the conglomerate’s stock after selling 3,322 shares during the quarter. Cibc World Market Inc.’s holdings in Danaher were worth $20,603,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Capital International Investors lifted its stake in shares of Danaher by 1.9% in the third quarter. Capital International Investors now owns 16,758,240 shares of the conglomerate’s stock valued at $3,318,926,000 after buying an additional 312,951 shares in the last quarter. Norges Bank bought a new position in shares of Danaher in the fourth quarter valued at $2,177,106,000. Generation Investment Management LLP lifted its stake in shares of Danaher by 34.0% in the third quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate’s stock valued at $1,319,354,000 after buying an additional 1,689,020 shares in the last quarter. Legal & General Group Plc lifted its stake in shares of Danaher by 1.0% in the fourth quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock valued at $1,029,061,000 after buying an additional 43,169 shares in the last quarter. Finally, Fisher Asset Management LLC lifted its stake in shares of Danaher by 1.8% in the fourth quarter. Fisher Asset Management LLC now owns 4,446,976 shares of the conglomerate’s stock valued at $1,018,002,000 after buying an additional 77,757 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Price Performance

Danaher stock opened at $184.45 on Friday. The business’s 50 day simple moving average is $181.29 and its 200 day simple moving average is $206.19. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a market cap of $130.55 billion, a price-to-earnings ratio of 35.68, a PEG ratio of 2.49 and a beta of 0.81. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last released its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. During the same period last year, the business posted $1.88 earnings per share. The business’s revenue for the quarter was up 3.7% on a year-over-year basis. Sell-side analysts forecast that Danaher Corporation will post 8.43 EPS for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s dividend payout ratio (DPR) is 30.95%.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on DHR shares. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Wells Fargo & Company lowered their target price on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a report on Wednesday, April 22nd. JPMorgan Chase & Co. lowered their target price on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. TD Cowen lowered their target price on shares of Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Finally, Evercore increased their target price on shares of Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a report on Tuesday, April 21st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $235.14.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.